# Phase 1 syndrome trials recruiting: 94 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 94 trials in phase 1 for syndrome that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 1 syndrome trials: 94 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-1/syndrome

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 94
- Recruiting or not yet: 94
- Read on: November 19, 2026

## Trials

The 25 newest of 94, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 16, 2026 | NCT07939594 | An Evaluation of the Potential for VH4011499 Drug-drug-interactions | ViiV Healthcare | Phase 1 | Not yet recruiting | HIV Infections | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07939594) |
| November 13, 2026 | NCT07934719 | Mass Balance and Absolute Bioavailability of \[14C\]-VH4011499 | ViiV Healthcare | Phase 1 | Not yet recruiting | HIV Infections | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07934719) |
| November 10, 2026 | NCT07927972 | Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Subcutaneous Injections of Elamipretide in Pediatric Subjects With Barth... | Stealth BioTherapeutics Inc. | Phase 1 | Not yet recruiting | Barth Syndrome | 6 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07927972) |
| November 10, 2026 | NCT07927218 | Study of Food Effects of VV261 Tablets in Healthy Trial Participants | Vigonvita Life Sciences | Phase 1 | Not yet recruiting | Severe Fever With Thrombocytopenia Syndrome | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07927218) |
| November 9, 2026 | NCT07926893 | Lenalidomide and Cosibelimab for the Treatment of Relapsed/Refractory Mycosis Fungoides or Sézary Syndrome | City of Hope Medical Center | Phase 1 | Not yet recruiting | Recurrent Mycosis Fungoides, Recurrent Sezary Syndrome, Recurrent Transformed Mycosis Fungoides, Refractory Mycosis... | 14 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07926893) |
| October 30, 2026 | NCT07906145 | A Phase 1 Study of QLS2416 Injection in Participants With Autoimmune Diseases | Shanghai Qilu Pharmaceutical Research and Development Center LTD | Phase 1 | Not yet recruiting | Systemic Lupus Erythematosus, Rheumatoid Arthritis (RA), Primary Sjögren's Syndrome (pSS), Systemic Sclerosis (SSc) | 76 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07906145) |
| October 27, 2026 | NCT07897136 | CLL-1/CD70 Dual-Target CAR-T Cell Therapy for Acute Myeloid Leukemia | Sponsor not shown (see the record) | Phase 1 | Not yet recruiting | Acute Myeloid Leukemia (AML), Relapsed/Refractory Acute Myeloid Leukemia | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07897136) |
| October 20, 2026 | NCT07882953 | SIMBA in Irritable Bowel Syndrome (IBS) | University of Calgary | Phase 1 | Not yet recruiting | Irritable Bowel Syndrome (IBS), Microbiome | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07882953) |
| October 14, 2026 | NCT07873931 | A Study of BMS-986553 in Participants With Refractory Autoimmune Diseases | Bristol-Myers Squibb | Phase 1 | Not yet recruiting | Systemic Lupus Erythematosus, Sjögren's Disease, Rheumatoid Arthritis, Idiopathic Inflammatory Myopathies, Systemic... | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07873931) |
| September 25, 2026 | NCT07841002 | CLL-1-Targeted In Vivo CAR-T Cell Immunotherapy for Relapsed/Refractory Acute Myeloid Leukemia | Sponsor not shown (see the record) | Phase 1 | Not yet recruiting | Relapsed/Refractory Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia (AML) | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07841002) |
| September 3, 2026 | NCT07801456 | A Clinical Study to Evaluate the Safety and Immunogenicity of a Higher Dose of the Study Vaccine, VIR-1388, in HCMV-seropositive Adult... | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 | Not yet recruiting | Cytomegalovirus (CMV), HIV (Human Immunodeficiency Virus) | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07801456) |
| July 28, 2026 | NCT07732309 | A Study of ATG-201 in Adult Participants With Autoimmune Diseases | Antengene Biologics Limited | Phase 1 | Recruiting | Systemic Lupus Erythematosus, Systemic Sclerosis (SSc), Sjogren's Disease, Autoimmune Diseases | 149 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07732309) |
| July 24, 2026 | NCT07726914 | Study to Compare the Plasma Concentration of Belumosudil Given as an Oral Suspension and as a Tablet to Healthy Adult Male Participants | Sanofi | Phase 1 | Not yet recruiting | Chronic Graft Versus Host Disease | 58 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07726914) |
| July 22, 2026 | NCT07718997 | A Multiple Baseline Feasibility Trial of Social Management Training for People With Sex Chromosome Aneuploidies | University of Oslo | Phase 1 | Recruiting | Sex Chromosome Disorders | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07718997) |
| July 20, 2026 | NCT07712939 | A Phase 1, First-in-Human Study of CND319 in Healthy Participants and Patients With Rheumatic Diseases | Candid Therapeutics | Phase 1 | Recruiting | Healthy Participants Study, Rheumatoid Arthritis, Sjogren's Syndrome | 105 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07712939) |
| July 13, 2026 | NCT07699783 | Transcranial Ultrasound Stimulation for Tourette Syndrome | University of Calgary | Phase 1 | Not yet recruiting | Tourette Syndrome | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07699783) |
| July 13, 2026 | NCT07698600 | A Clinical Trial to Look at the Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Living With or Without HIV | BioNTech SE | Phase 1 | Recruiting | HIV -1 Infection | 126 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07698600) |
| June 16, 2026 | NCT07649265 | A Trial in Healthy Adult Participants and Adults With Autoimmune Diseases to Test How HBM7020 is Tolerated and How it Behaves in the Body | Otsuka Pharmaceutical Development & Commercialization, Inc. | Phase 1 | Recruiting | Rheumatoid Arthritis, Systemic Lupus Erythematosus, Systemic Sclerosis, Sjögren's Disease | 63 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07649265) |
| June 12, 2026 | NCT07646028 | R-3750 in Patients With Late-Stage Acute Respiratory Distress Syndrome (ARDS) | Rise Therapeutics LLC | Phase 1 | Not yet recruiting | Acute Respiratory Distress Syndrome | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07646028) |
| June 10, 2026 | NCT07640308 | Bio-Manguinhos/Fiocruz COVID-19 (mRNA) Vaccine Booster | The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) | Phase 1 | Not yet recruiting | Severe Acute Respiratory Syndrome (SARS-CoV-2 Virus) | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07640308) |
| June 9, 2026 | NCT07636928 | Mass Balance and Absolute Oral Bioavailability of \[14C\]VH4524184 | ViiV Healthcare | Phase 1 | Recruiting | HIV Infections | 9 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07636928) |
| June 9, 2026 | NCT07635992 | A Clinical Study Evaluating the Safety, Tolerability, and Effect on HIV Reservoir of Ibalizumab Combined With Chidamide (a Histone... | First Affiliated Hospital of Zhejiang University | Phase 1 | Not yet recruiting | HIV (Human Immunodeficiency Virus) | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07635992) |
| June 2, 2026 | NCT07619885 | The Pharmacokinetics and Pharmacodynamics Study of Evategrel CG-0255 Besylate）and Plavix® in Healthy Participants | Shanghai CureGene Pharmaceutical Co., Ltd. | Phase 1 | Recruiting | Acute Coronary Syndromes (ACS), Recent Myocardial Infarction, Recent Stroke, Peripheral Arterial Disease | 136 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07619885) |
| May 22, 2026 | NCT07600788 | A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137 Injection in Participants With Mild to Moderate Liver... | Ausper Biopharma Co., Ltd. | Phase 1 | Recruiting | Chronic Hepatitis B | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07600788) |
| May 22, 2026 | NCT07600775 | A Clinical Trial of MK-8527 and Rifampin in Adult Participants With Latent Tuberculosis Infection (MK-8527-019) | Merck Sharp & Dohme LLC | Phase 1 | Not yet recruiting | Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis | 14 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07600775) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| China Immunotech (Beijing) Biotechnology Co., Ltd. | 5 |
| [ViiV Healthcare](https://specstream.ai/data/clinical-trials/company/viiv-healthcare) | 5 |
| The Children's Hospital of Zhejiang University School of Medicine | 3 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| University of Calgary | 2 |
| Emory University | 2 |
| National Cancer Institute (NCI) | 2 |
| Rise Therapeutics LLC | 2 |
| Lineage Cell Therapeutics, Inc. | 1 |
| West China Hospital | 1 |
| University of Oslo | 1 |
| Antengene Biologics Limited | 1 |
| The First Affiliated Hospital of Soochow University | 1 |
| Baylor College of Medicine | 1 |
| FBD Biologics Limited | 1 |
| University of the Punjab | 1 |
| Asia Cell Therapeutics (Shanghai) Co., Ltd. | 1 |
| [Vigonvita Life Sciences](https://specstream.ai/data/clinical-trials/company/vigonvita-life-sciences) | 1 |
| The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) | 1 |
| Vanderbilt University | 1 |
| U.S. Army Medical Research and Development Command | 1 |
| Unravel Biosciences, Inc. | 1 |
| Shanghai Qilu Pharmaceutical Research and Development Center LTD | 1 |
| Immuno Cure Holding (HK) Limited | 1 |
| Yale University | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 42 |
| China | 24 |
| Taiwan | 4 |
| France | 4 |
| Italy | 4 |
| Spain | 4 |
| Australia | 4 |
| Canada | 3 |
| Germany | 3 |
| Netherlands | 3 |
| Poland | 3 |
| Norway | 2 |
| Pakistan | 2 |
| Japan | 2 |
| Uganda | 1 |
| Colombia | 1 |
| Hong Kong | 1 |
| Israel | 1 |
| Belgium | 1 |
| Austria | 1 |
| Bulgaria | 1 |
| Croatia | 1 |
| Czechia | 1 |
| Hungary | 1 |
| Portugal | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Podiatrists in the United States](https://specstream.ai/data/businesses/podiatrists/united-states)
- [Australian restaurants in the United States](https://specstream.ai/data/businesses/australian-restaurants/united-states)
- [Fireplace services in the United States](https://specstream.ai/data/businesses/fireplace-services/united-states)
- [Pizza restaurants in the United States](https://specstream.ai/data/businesses/pizza-restaurants/united-states)
- [Armenian restaurants in the United States](https://specstream.ai/data/businesses/armenian-restaurants/united-states)
- [Fertility clinics in the United States](https://specstream.ai/data/businesses/fertility-clinics/united-states)
